roborates the truth of both statements. Kolmer and his coworkers (3) state that the presence of hemagglutination and hemolysis bears no direct relation to each other. Their experiments are open to the same criticism as before, in that they were working with various sera and cells, the blood groups of which were unknown. It is possible that their failure to obtain hemolysis when hemagglutination was present was due to an insufficient amount of complement. The two instances in which they obtained hemolysis when no macroscopic agglutination was present is harder to explain and has never been encountered in our work with the human blood groups.
A failure to obtain hemolysis in group cells or by group sera, the groups of which had previously been determined by the agglutination method, was never encountered in this work, nor was hemolysis ever obtained when agglutination was absent. It is true, however, that, quantitatively, the hemolysin content of a human serum does not necessarily correspond to the agglutinin content. A serum giving strong agglutination for a certain group of cells may give slight or no noticeable hemolysis, in the quantity used, against the same cells. The hemolysin is present, however, and can always be demonstrated, when sufficient complement is present, by increasing the amount of serum.
It seems correct, therefore, to substitute the word "hemolyzes" for "agglutinates" in Moss' classification of the human blood groups;
Presence of a Natural Specific Hemolysin in Guinea Pig Serum for
Group I and Group H Human Cells.
Trouble has been experienced at various times in our complement fixation work by encountering complement that was hemolytic for the particular cell suspension being used. This was never a constant factor and would often be absent or at least not noticeable in the control tube containing complement and cells in the complement titration. The presence of this hemolysin was particularly noted in France while using an anti-sheep hemolytic system, and at one time became a serious problem, warranting the issuance of a special circular by the Director of the Division of Laboratories and Infectious Diseases warning all laboratories to be on the watch for it and suggesting that the serum of each guinea pig should be tested against the cell suspension used that day, before the sera were pooled for use as complement. Certain investigations were undertaken at this time under the direction of Major R. G. Hussey and with the benefit of occasional advice from Colonel Zinsser. The pressure of routine work was so great, however, that nothing definite was accomplished.
In some of the experimental work in France it was shown that the serum of these guinea pigs often contained hemolysins for both human and bovine ceils, although these hemolysins were not constant and did not parallel the natural anti-sheep hemolysin present. With this fact in mind, since changing to the anti-human hemolytic system, I have tested out a portion of each guinea pig serum, before it was pooled as complement, against the human cell suspension being used that day. It was often observed and demonstrated that on certain days practically all the guinea pig serum would contain a sufficient quantity of anti-human hemolysin to render it unfit for use as complement. On these occasions many guinea pigs would have to be bled before it was possible to find three or four sera suitable for pooling and use as complement.
While engaged in some work with the four groups of human cells it was observed, in certain control tubes containing only complement and cells, that the tubes containing complement and Group I cells, and complement and Group II ceils, showed a marked agglutination of the cells. The control tubes with Group III and Group IV cells 34  +  ++  ++  ++  +  ++  ++  ++  35  +-+  ++  ++  -+-+  ++  36  +  ++  ++  ++  +  I ++  ++  ++ 4-4-indicates complete hemolysis; q-, marked hemolysis; -{--, slight hemolysis; -, no hemolysis. showed no agglutination. On the assumption that when hemagglutinins were present, hemolysins could usually be demonstrated, a large number of guinea pigs was tested against different human cell suspensions of Groups I, II, III, and IV. The guinea pig sera were diluted to 40 per cent, which is the strength of the complement as used in the Army Medical School, and increasing quantities, 0.1, 0.2, 0.3, and 0.4 cc., were set up against the cell suspensions of the four human groups. Larger quantities were not used, for the complement unit in the anti-human system generally falls in the neighborhood of 0.04 or 0.05 cc. Quantities as large as 0.2 cc. are seldom if ever used, and for practical purposes it was not considered necessary to use quantifies larger than 0.4 cc. The results on over 50 guinea pigs were striking. No hemolysis whatever was obtained with any of the guinea pig sera with Group III and Group IV human cells. The results with Group I and Group II human cells are shown in Table I . + + indicates complete hemolysis; +, marked hemolysis; +-, slight hemolysis; -, no hemolysis.
In view of the fact that these guinea pig sera in the same quantities were absolutely negative for Group III and Group IV cells, the results indicate that there is, apparently, a specific hemolysin in guinea pig serum, in quantities that would be a factor if used as complement selective against two groups of human red blood cells. No hemolysin is present for the other two groups of cells in quantities far in excess of any that might be used in complement fixation reactions with an anti-human hemolytic system.
A fact of some importance is that these examinations were made at different times over a period of several months, that the guinea pigs were obtained from various lots purchased in Pennsylvania, Virginia, Maryland, and the District of Columbia, and that in all the work the different human group cells were not obtained from any one set of individuals but from a large number of people, the only requirement being that they fell within the proper blood group.
The specificity of this hemolysin was next determined by the ~b-sorption, in the cold, of many of the guinea pig sera with the different group cells. A specimen of guinea pig serum, 40 per cent, was tested against the four group cell suspensions. A portion of this serum was then treated with Group I cells, at freezing temperature, for ½ hour, rapidly centrifuged, the supernatant serum pipetted off and retested against all four group cell suspensions. Three other portions of the untreated serum were then absorbed with the cells of Groups II, III, and IV respectively, in the same manner, and all separately retested with the cell suspensions of all four groups. A detailed tabulation of the experiments will not be given here, but the results were invariably constant and sample protocols are shown in Tables II to VI. These experiments show that the natural anti-human hemolysin present in guinea pig serum can be absorbed by the cells of either Group I or Group II, but is not absorbed by the cells of either Group III or Group IV, thus proving the specificity of the hemolysin. As stated before, these experiments were done many times with unvarying results.
Influence of the Isohemolysins in Human Sera upon Human Cell
Suspensions.
The influence of the isolysins in sera received for Wassermann test and their relation to the blood group of the cell suspension used were next investigated.
Twenty-three sera, upon which tests had been run, were selected at random. Group I cells were first selected as being, theoretically, the cells most apt to be acted upon by the largest number of sera. 0.1 cc. of the inactivated serum, 0.1 cc. of the Group I cell suspension, and one unit. of complement, as determined for the tests that day, were made up to a total volume of 1 cc. with saline solution and incubated in the water bath at 37°C. for 1 hour. Three of the sera gave complete hemolysis of the cells, nine gave marked hemolysis, six gave slight hemolysis, while five gave no appreciable hemolysis at the end of 1 hour. The three sera that gave complete hemolysis with Group I cells were then set up with a suspension of Group IV human cells, with the same quantities and technique. No hemolysis took place with the Group IV cell suspension. The results with Group I cells were so suggestive that steps were immediately taken to continue the work with cells from all four of the human blood groups.
Twenty sera were next tested with cell suspensions of all four groups. The results are shown in Table VII . Hemolysis, marked or partial, took place with practically all the human sera and Group I cells. Variations were shown in their action on Group II and Group III cells, according to the blood group to which each serum belonged. The Group IV cell suspension was not hemolyzed by any of the sera. Although the one unit of complement used was a very small quantity (0.04 cc.) the possibility of the influence of the natural anti-human hemolysin in the complement against Group I and Group II cells could not be overlooked. The above experiment was repeated with complement from which the anti-human hemolysin had been previously absorbed. The complement was prepared in the usual way and was tested against all four groups of human ceils. The natural hemolysin was then absorbed from it by treating it with Group II cells, at freezing temperature, for ½ hour. After absorption the complement was retested against all four group cell suspensions to verify the complete absorption of the hemolysin, in at least eight times the quantity used as one unit. Twenty-six sera were tested, as shown in Table VIII , the quantities used being the same as in the first experiment (Table VII) .
The results obtained were similar to those shown in Table VII . With the natural hemolysin absorbed from the complement, hemolysis of some degree took place with practically all the sera and Group I cells, and with many of the sera and Group II and Group III cells, showing that the natural anti-human hemolysin present in the one unit of complement used in the first experiment was not entirely responsible for the hemolysis obtained with Group I and Group II cells.
The foregoing work has made it evident that, theoretically at least, the blood group to which the cell suspension belonged might play as important a part in the anti-human complement fixation reactions as the presence of natural anti-sheep amboceptor in human serum was supposed to play in the methods in which an anti-sheep hemolytic system was used.
Influence of an Excess of Amboceptor upon Complement Fixation
Reactions in Which an Anti-Human Hemolytic System Is Used.
To determine the real practical importance of both the isolysins in human serum and the natural anti-human hemolysin in guinea pig serum, a series of complement fixation tests was done upon a number of sera which had given strongly positive, weakly positive, and doubtful reactions in the routine tests, all four group cells for each serum tested being used. Two units of complement were used, the titer having been determined for use in the routine tests that day. The results are shown in Table IX .
Of the twenty-six sera tested there were but eleven that gave the same reacton with all four group cells, three being known negative Particular attention was paid to technique in these tests, all being run at the same time under identical conditions, the same reagents being used for all, and all steps being strictly controlled. Sera 20, 25, and 26 were known negative sera that were introduced as hemolytic and antigen controls. sera introduced as controls. The fifteen sera showing variations, as a rule, gave the weakest reaction with Group I cells, but the results with Group II and Group III cells were sufficiently marked to show that the group of the cell suspension used plays an important part in the strength of the reaction obtained with the human hemolytic system. ++ indicates complete inhibition of hemolysis; +, partial inhibition of hemolysis; + -, slight inhibition of hemolysis; -, complete hemolysis.
As the above tests had been done with the reagents and technique as ordinarily used in the routine complement fixation reactions, it was difficult to judge just how much of the variation in the reading was strictly due to the isolysins in the human sera and how much to the natural anti-human hemolysin present in the complement used. A second set of tests was run with various sera, all four groups of cell suspensions being used for each serum. The complement employed had had the natural anti-human hemolysin absorbed from it. It was prepared in the usual way and tested against all four group cell suspensions. The natural hemolysin was then absorbed by treating the complement, at freezing temperature, with Group II human ceils. After absorption the complement was retested against cell suspensions of all of the four groups to verify the complete absorption of the hemolysin. The unit of complement was determined by titrating against Group IV cells and two units were used in the tests. The same precautions as to technique, controls, etc., were observed here as with the first set of tests. Results were obtained as shown in Table X .
With the seventeen sera tested there were but seven that gave the same reaction with all four cell suspensions, five of these being strongly positive and two being known negative sera introduced as controls. With the ten remaining sera, weaker reactions were obtained with Group I, Group II, and Group III cells than were obtained with Group IV cells.
These results show that the isolysins in human serum are the important factor in the variations in the readings of the reaction obtained with the different group cell suspensions. The natural anti-human hemolysin in guinea pig serum may be a contributing factor to the resultant excess of amboceptor present when Group I or Group II cells are used, but it is of less importance, in the quantity ordinarily used in a two unit dose, than the human isolysins.
All the work so far points to the necessity, from the standpoint of accuracy, of using erythrocytes from a Group IV individual when preparing cell suspensions for work with a complement fixation reaction in which an anti-human hemolytic system is used. This is entirely compatible with our knowledge of the human blood groups, as Group IV cells are not acted upon by the isohemolysins in the serum of any of the human blood groups.
Human Blood Groups in Complement Fixation Reactions with an AntiSheep Hemolytic System.
Very early in the work reported above, the suggestion was made to the writer that the presence of natural anti-sheep hemolysin in human serum might bear some relation to the human blood groups. This could operate in two ways--either there might be certain of the human blood groups whose sera contained hemolysin for all sheep cells, or, more possibly, there might be definite groups among sheep and it would perhaps be possible to select a sheep of a certain group whose cells might conceivably correspond to the human Group IV cells and contain no receptors for the hemolysins present in human serum. Such an observation as the latter, if it could be substantiated, would naturally be very important in complement fixation reactions with an anti-sheep hemolytic system. The problem of the effect of various hflman sera upon different sheep cells was approached by testing ten human sera, the blood group to which each belonged being known, against eleven different sheep cell suspensions. The technique used was that employed in the usual quarter unit Wassermann test. Inactivated human serum was used in a dose of 0.05 cc., complement was a 10 per cent dilution of pooled guinea pig serum, and the cell suspensions employed were all 5 per cent with a dosage of 0.25 cc. The complement was fitrated against a sheep cell suspension obtained from our own sheep, whose cells are not included in the eleven tested as shown in Table XI . The complement was also tested for hemolytic properties in a two unit dose against all of the eleven sheep cell suspensions used. The results are given in Table XI . In Tables XI and XII are given the results on twenty-six different human sera, comprised in the commonest blood groups, ten of the sera being tested against eleven sheep cell suspensions and sixteen of the sera against twelve different sheep cell suspensions. All efforts to corelate these results with the various blood groups of the sera tested were futile. There appeared to be no regularity with which the serum from any particular blood group acted upon the cell suspensions.
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On the other hand, there was a marked variation in the degree of hemolysis obtained with many of the individual sera against the different sheep ceils. With certain sera this would vary from no hemolysis with one sheep cell suspension to complete hemolysis with another cell suspension, and almost all the human sera showed some variation in their action against the various cell suspensions. This fact is undoubtedly of some significance, although as can be seen, among the twenty-three sheep cell suspensions tested there was no single sheep whose cells failed to contain receptors for the anti-sheep hemolysin present in at least two or more of the human sera.
Further investigation along this line is being continued and these results, while unsatisfactory, are reported in order that other workers may investigate this variation in the susceptibility of different sheep cells to the natural anti-sheep hemolysin present in human serum.
Natural Anti-Sheep Hemolysin in Guinea Pig Serum.
Another problem to be considered was the occasional presence of natural anti-sheep hemolysin in guinea pig serum used as complement. That this may be of considerable importance in occasional instances has been shown above. During one period in which it was encountered in France approximately 150 guinea pigs from one lot had to be bled in order to obtain sufficient non-hemolytic serum that could be pooled and used as complement in the routine work. It occurred sporadically at that particular laboratory over a long period of time. It seemed strange, however, that during this period many competent observers in various subsidiary laboratories in France failed to find this hemolysin at any time in their guinea pig serum. At the time this was ascribed to a probable difference in the guinea pigs being used, differences in breeding and inbreeding, as well as the possible influence of environment and food all being considered.
The results reported here would indicate that these views were probably erroneous and that the trouble was possibly due to a certain type or group of sheep cells for which certain guinea pig serum contains hemolysin, rather than to any inherent difference in the individual guinea pigs. This explains the failure of certain observers to confirm our observation, the particular sheep cells that they used not being susceptible to the action of, or not containing receptors for the hemolysin present in guinea pig serum. At the laboratory in question three sheep were in use most of the time, and so far as the writer knows, no strict rule was in force relative to the rotation of the bleedings. The sheep that was easiest to catch and hold was usually the sheep that was bled the most often.
When the work on the natural anti-human hemolysin in guinea pig serum showed that this hemolysin was selective for Group I and Group II human cells, it suggested the possibility of the presence of a natural anti-sheep hemolysin in guinea pigs which would only be active against a certain type or group of sheep cells. A large number of guinea pigs was tested against many sheep cell suspensions on different occasions. The guinea pig serum was used in a dilution of 10 per cent in amSunts as indicated in Table XIII ; cell suspensions were 5 per cent with a dose of 0.25 cc. In order to eliminate the possibility of anficomplementary action by~ any of the sheep cells, a hemolytic control was run on each cell suspension, with 0.2 cc. of the 10 per cent guinea pig serum and one unit of an artificial antisheep amboceptor. Detailed tabulation of 0ae results need not be given, but a sample protocol of the test of four guinea pigs against seven sheep cell suspensions is shown in Table XIII .
In addition to the tests described above, twelve guinea pig sera against a total of fourteen different sheep cell suspensions gave negative results, which would indicate that it is a relatively uncommon condition for the average sheep cells to contain receptors for the natural hemolysins present in guinea pig serum in the quantities ordinarily used in complement fixation work. Table XIII, however, shows graphically what would happen if the sheep used for preparing the cell suspension should correspond to Sheep L. These results would also explain the fact that a natural antl-sheep hemolysin was encountered with such frequency at one laboratory in France, while other observers failed to find this hemolysin in guinea pigs in use at other laboratories. The possibility of its occurrence, however slight, should be considered when selecting a sheep for complement fixation work. 1. The presence of a natural antl-human hemolysin, only active against Group I and Group II cells, was demonstrated in over 50 guinea pigs, obtained from different sections of the surrounding country. It was shown that, in a majority of the sera tested, this hemolysin would be a contributing factor to an excess of amboceptor in the reaction, in the quantifies of complement used in an antihuman complement fixation reaction. The hemolysin is specific, in as far as it can be absorbed with either Group I or Group II cells, but cannot be absorbed, with Group III or Group IV cells.
2. To determine the effect of the isohemolysins in human serum, twenty sera were tested against cell suspensions of the four human groups. Tests were also run with twenty-six human sera against all four group cell suspensions, with complement that had the natural anfi-human hemolysin absorbed from it. In both experiments various degrees of hemolysis were obtained with all but two sera against cell suspensions from Groups I, II, and III, but no hemolysis was obtained with any serum against a Group IV cell suspension.
3. The importance of the human isohemoiysins and the natural anti-human hemolysin in complement was demonstrated by performing complement fixation tests upon twenty-six human sera, cell suspensions of all four human groups for each serum tested being used. A marked variation in the reaction occurred with a large percentage of the sera tested. This variation in a single serum might be as great as a negative reading with Group I cells to a double plus reading with Group IV cells.
4. That the isohemolysins, alone, in human serum are of importance in the reaction was shown by running complement fixation tests upon seventeen human sera with the four group cell suspensions and complement from which the natural anti-human hemolysin had been absorbed. Results showed a much weaker reaction, m a large number of the sera, with Group I, Group II, and Group HI cells than with Group IV cells.
5. Experiments to determine a relation between the human blood groups and natural anti-sheep hemolysin present in human serum gave negative results. It was shown, however, with twenty-six human sera tested against twenty-three different sheep cell suspensions that there is a wide variation in the activity of the natural anti-sheep amboceptor present in any human serum when it is tested against different sheep cell suspensions. A human serum capable of completely hemolyzing the cells of one sheep may fail to give any hemolysis whatever when tested against another sheep cell suspension.
6. Tests were made for natural anti-sheep hemolysin in guinea pig serum. The serum from sixteen different guinea pigs was tested against a total of twenty-one sheep cell suspensions. A natural anti-sheep hemolysin was present in all the guinea pigs tested against one of the sheep cell suspensions. The same guinea pigs tested against the other sheep cell suspensions failed to show any hemolysis.
CONCLUSIONS.
I. In the Wassermann reaction it should be taken into account that in addition to any complement-flxing bodies which may or may not be present, each serum tested belongs to a definite blood group and each human cell suspension used belongs to a definite blood group. These factors have never been sufficiently realized and must be taken into consideration if possible sources of error are to be excluded.
2. In addition to the isohemolysins in human serum, an additional source of error, when human cell suspensions are made up at random, is introduced by the presence of a natural anti-human hemolysin in guinea pig serum selective for Group I and Group II human cells.
3. Erythrocytes from a Group IV individual (Moss' classification) are never acted upon by the isohemolysins present in human serum nor are they acted upon by the natural anti-human hemolysin present in guinea pig serum.
4. Erythrocytes should always be obtained from a Group IV individual when preparing cell suspensions for complement fixation reactions in which an anti-human hemolytic system is used.
5. An unexplained variation in the activity of the natural antisheep hemolysin in human serum, when tested against different sheep cell suspensions, would seem to be worthy of further investigation.
6. The presence of a natural anti-sheep hemolysin in guinea pig serum used as complement, apparently only active against a certain type or group of sheep cells, is a factor to be considered when selecting a sheep for complement fixation work.
I wish to express my appreciation to Colonel F. F. Russell, Colonel C. F. Craig, and Major H. J. Nichols for helpful criticisms during the progress of this work.
